WEST PHARMACEUTICAL SERVICES, INC. Interest Expense Nonoperating
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Interest Expense Nonoperating of $2.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $2.60M, a 2500.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $1.90M, a 375.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. interest expense nonoperating for the quarter ending 2025-12-31 was -$200.00K.
- WEST PHARMACEUTICAL SERVICES, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $200.00K, a 71.43% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. interest expense nonoperating for fiscal 2025 was $500.00K, a 83.33% decline from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. interest expense nonoperating for fiscal 2024 was $3.00M, a 66.67% decline from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. interest expense nonoperating for fiscal 2023 was $9.00M, a 13.92% increase from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. interest expense nonoperating for fiscal 2022 was $7.90M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.60M 10-Q · filed 2026-07-23 | $4.50M 10-Q · filed 2026-07-23 | $4.30M derived: sum of 3 quarters · filed 2026-07-23 | $4.50M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $1.90M 10-Q · filed 2026-04-23 | $1.70M derived: sum of 2 quarters · filed 2026-04-23 | $1.90M derived: sum of 3 quarters · filed 2026-04-23 | $2.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $100.00K derived: sum of 3 quarters · filed 2026-07-23 | $500.00K 10-K · filed 2026-02-17 |
| 2025-09-30 | $200.00K 10-Q · filed 2025-10-23 | $300.00K derived: sum of 2 quarters · filed 2026-07-23 | $700.00K 10-Q · filed 2025-10-23 | -$100.00K derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $100.00K 10-Q · filed 2026-07-23 | $500.00K 10-Q · filed 2026-07-23 | -$300.00K derived: sum of 3 quarters · filed 2026-07-23 | $400.00K derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $400.00K 10-Q · filed 2026-04-23 | -$400.00K derived: sum of 2 quarters · filed 2026-04-23 | $300.00K derived: sum of 3 quarters · filed 2026-04-23 | $1.80M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | -$800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$100.00K derived: sum of 2 quarters · filed 2026-02-17 | $1.40M derived: sum of 3 quarters · filed 2026-02-17 | $3.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $700.00K 10-Q · filed 2025-10-23 | $2.20M derived: sum of 2 quarters · filed 2025-10-23 | $3.80M 10-Q · filed 2025-10-23 | |
| 2024-06-30 | $1.50M 10-Q · filed 2025-07-24 | $3.10M 10-Q · filed 2025-07-24 | ||
| 2024-03-31 | $1.60M 10-Q · filed 2025-04-24 | |||
| 2023-12-31 | $9.00M 10-K · filed 2026-02-17 | |||
| 2023-06-30 | $2.70M 10-Q · filed 2024-07-25 | $4.90M 10-Q · filed 2024-07-25 | ||
| 2022-12-31 | $7.90M 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |